Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

Abstract Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil. To date, there have been relatively few articles comparing RT and propofol for general anesthesia. This study ai...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Wenchen Luo, Minli Sun, Jie Wan, Zhenyu Zhang, Jian Huang, Jinlin Zhang, Wanxia Xiong, Lirong Xia, Peiyao Xu, Changhong Miao, Xuesong Zhang, Mingyue Liu, Jing Zhong
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2023-05-01
Sarja:	BMC Anesthesiology
Aiheet:	Remimazolam tosilate Propofol Flumazenil General anesthesia Day surgery
Linkit:	https://doi.org/10.1186/s12871-023-02092-2
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!